Calluna Pharma has announced that it has appointed Margrethe Sørgaard as senior vice president of clinical operations and pharmacovigilance.

Sakura Finetek Europe has announced the appointment of Jaap Stuut as president and general manager, effective immediately.

Harness Therapeutics has announced the appointment of Meenu Chhabra Karson as chair of its board of directors.

Single Technologies has announced that it has appointed Bob Kain as an advisor to support the commercialisation of its 3D sequencing system.

Nuclera has announced that it has appointed Joseph Bertelsen as chief commercial officer (CCO).

BenevolentAI has announced that Dr Daniel Neil, current chief technology officer (CTO) is stepping down, to be succeeded by Dr James Malone, who joins the company in April.

Vynamic has announced the appointment of Gemma Pfister as head of life sciences Europe.

Parexel has announced that its CEO, Jamie MacDonald will retire, with the company’s current chief operating and growth officer Peyton Howell taking over as CEO, effective 15 May 2024.

Amylyx Pharmaceuticals has announced that it has appointed Andrew Caldwell to general manager UK and Ireland.

French biotech company StromaCare has announced the appointment of Georges Rawadi as chief executive officer (CEO).

AdhereTech has announced that it has appointed Paul Sekhri to its board of directors, having begun his new role on 7 February 2024.

Cuttsy+Cuttsy has announced the appointment of Jon Hume as commercial director, taking his new role from 1 March 2024.